Conditions: Diabetic Foot Ulcer (DFU); Granulation of Chronic Diabetic Wounds
Interventions: Drug: an allogenic cell-based product, containing living human bone marrow-derived mesenchymal stem cells (MSCs) and MSCs differentiated into adipocytes on a porous chitosan-gelatin matrix; Other: Standard of Care of Diabetic Foot Ulcers
Sponsors: Ayu, Inc.; MCRA
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
